Pfizer shows profit growth from cost cuts and steadier COVID sales

“Our revenue volatility is largely in the past as COVID-related uncertainties have diminished,” Pfizer’s finance chief David Denton said.

Leave a Reply

Your email address will not be published. Required fields are marked *